To all customers

Loparex Group Sale Completed

It’s official! The sale of Loparex Group to ABN AMRO Capital has been completed, effective today.

The sale has been structured as a management buy out so that you will continue to work with and know the management team that already understands your business. Joining the team as Loparex Group President & Chief Executive Officer is Pentti Kallio. Mr. Kallio will be based in Apeldoorn, The Netherlands where the Group Head Office will be located. The on-going team consists of Paul van Pinxteren, Chief Financial Officer for Loparex Group; Jack Taylor, President, and Jim Miksta, Senior Vice-President, Loparex Inc, located in Willowbrook, Illinois, USA; Raimo Pitk?nen, Managing Director, Loparex Limited, Glossop, UK; and Andie Ho, Managing Director, Loparex Asia Pacific, based in Hong Kong. Heikki Kotala will become Managing Director of Loparex Oy, located in Lohja, Finland, effective September 1, and Jan Hilbrink will succeed him as Managing Director, Loparex BV, based in Apeldoorn.

All Loparex units are part of this sale so the supply arrangements that have been servicing your operations will not change. Long-term supply agreements have been transacted so base papers previously supplied internally will continue to be available.

Although our ownership has changed, the values and principles you have come to expect from Loparex …that is, responding to your needs for quality release liners delivered on-time and at a competitive price… remain unchanged. Our commitment to you as a valued customer is to continue to do “business as usual” with your same Loparex contacts. The Loparex team that has been working to support your business will continue to do so.

Johan Bjurstrom, Executive Director of ABN AMRO Capital stated that “when looking to acquire Loparex we were particularly attracted by the company’s strong market position, global presence and track record of growth. The company’s ability to deliver focused R&D and support its customers globally will be key success factors in Loparex’ path forward. ABN AMRO is looking forward to supporting Loparex with capital, international networks and its experience from numerous industry sectors”. ABN AMRO Capital will hold a controlling stake in Loparex with the operative management holding 8% of the share capital.

You can continue to rely on Loparex as your trusted supplier of quality release liners. Please call with any questions you have regarding this announcement.